The clinical study of SGN1 in the treatment of advanced malignant tumor
Latest Information Update: 05 Sep 2018
At a glance
- Drugs SGN-1 (Primary) ; SGN-1 (Primary)
- Indications Advanced breast cancer; Cancer; Colorectal cancer; Gastric cancer; Liver cancer; Non-small cell lung cancer; Pancreatic cancer; Sarcoma
- Focus Adverse reactions; Therapeutic Use
- Sponsors Guangzhou Sinogen Pharmaceutical
- 19 Jun 2018 New trial record